Key facts
- Notable investors include Shenzhen Yuanshan Private Equity Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Guoke Angzhuo
- ·The full record, as it builds
Funding rounds
No funding rounds for Guoke Angzhuo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guoke Angzhuo
Manufacturer of diagnostic and therapeutic imaging systems intended for clinical ultrasound applications. The company focuses on high-frequency transducer technologies, adaptive signal processing, and integrated imaging modules, offering capabilities such as real-time visualization, tissue characterization, and non-invasive therapeutic monitoring, serving healthcare institutions and medical device integrators to access precision-oriented, scalable ultrasound solutions that support diagnostic accuracy, treatment planning, and rehabilitation assessment.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2015
- Ownership
- Privately Held (backing)
Guoke Angzhuo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guoke Angzhuo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guoke Angzhuo in its N-PORT filings yet. We sweep new filings monthly.